| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5587970 | Journal of Clinical & Translational Endocrinology | 2017 | 34 Pages |
Abstract
Neither the neuroprotective substance HSP27 nor the inflammatory substances, MIF and PAI-1 were associated with measures of cardiovascular autonomic nerve function, but a deterioration of such function was observed in relation to increasing HbA1c in T1D during a 20-year follow-up period. Improved glucose control might be associated with protection against autonomic neuropathy in T1D.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Malin Zimmerman, Sara Rolandsson Enes, Hanna Skärstrand, Kaveh Pourhamidi, Anders Gottsäter, Per Wollmer, Olov Rolandsson, Gunilla Westergren-Thorsson, Lars B. Dahlin,